Benjamin T. Dake, SEE REMARKS at Aerovate Therapeutics, Inc. (AVTE), sold 19,142 shares at $24.52 ($470K) on 2023-02-06, disclosed to the SEC on 2023-02-08.
Open-market sale of $470k AVTE by SEE REMARKS. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.52 | 8,858 | $217K | 46.2% |
| 2 | $24.52 | 8,858 | $217K | 46.2% |
| 3 | $25.02 | 1,426 | $36K | 7.6% |
| Total | $24.56 avg | 19,142 | $470K | 100% |
| Filing → |
| AVTE | SELL | 2024-03-28 | $619K | — | Filing → |
| AVTE | SELL | 2024-03-27 | $192K | — | Filing → |
| AVTE | SELL | 2024-03-20 | $1.8M | — | Filing → |